KIF18B and hepatocellular carcinoma: Itzel et al. (2015) identified the regulatory role of KIF18 in hepatocellular carcinoma (HCC) by performing an oncogenic microarray meta-analysis. In vitro experiments also confirmed that the downregulation of KIF18B could induce G1 phase arrest of the cell cycle and inhibit the proliferation, migration and invasion of cervical cancer cells, while its overexpression could promote the proliferation, migration and invasion of cervical cancer cells (Wu et al., 2018).